跳至主要内容
临床试验/CTRI/2021/09/036861
CTRI/2021/09/036861招募中未知

Paired exosomal mRNA, tumoral somatic DNA sequencing and DNA methylation profiling in patients with brain tumours on radiology, to develop a liquid biopsy test.

Exsegen Genomics Research Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • (1) Subjects with suspected brain tumour on neuroimaging have not undergone any treatment for the suspected disease at the time of blood sample collection for this disease
  • (2) Age- any age with proper consent/assent
  • (3) Female patient - not pregnant
  • (4) Provision of signed and dated informed consent form
  • (5) Stated willingness to comply with all study procedures

排除标准

  • (1)Patients who fail to meet all of the above criteria for cases will be excluded. Failing to meet any single criteria would be sufficient grounds for exclusion.
  • (2)Prolonged cortico-steroid therapy, ideally steroid naïve
  • (3) Active or latent hepatitis B or active hepatitis C or any uncontrolled infection
  • (4) Human Immunodeficiency Virus (HIV) positive
  • (5) Active infections, COViD19, HIV, HPV, HBV, HCV, Tuberculosis etc.
  • (6) Patient has an investigational medicinal product within the last 30 days of blood collection.
  • (7) PET -CT scan in past 14 days

研究者

发起方
Exsegen Genomics Research Pvt Ltd

相似试验